Loading
Celanese Corp Stock: price and insider trades · United States
3 insiders bought €199k of shares over the last 90 days, the latest filed 17 Aug 2026.
Celanese Corp: what insiders have been doing
Celanese Corp, classified in the Chemicals & Materials sector, is a listed company based in Irving, United States, founded in 1918. Its insiders report their share dealings to SEC (Form 4). 9 insiders have disclosed 23 filings since 18 October 2025.
The flow runs one way only: 4 insiders bought (7 purchases totalling €511k) and nobody sold on the market. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The buyers include 2 senior executives, 1 finance chief and 1 chief executive. Kyrish Chuck filed the largest purchase, €176k, on 11 December 2025.
Within a 30-day window, 5 purchases overlapped with buying by a second insider. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The last purchase on record was published on 17 August 2026, which is 62 days ago. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade.
With 23 filings in twelve months, the company is more active than the median of 19 filings across the 5,811 companies we follow on the same exchange. Our records for Celanese Corp go back to 2016, with 24 purchases and 5 sales on the open market in total. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 December 2025), the company reported revenue of 9.54 bn USD and net income of -1.17 bn USD.
Elsewhere in the same sector, our signals recently picked up insider purchases at Culp Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
186
Thresholds
n/a
Buy Volume
€2M
24 ops. · all time
Sell Volume
€2M
5 ops. · all time
Who traded when
BuySaleChuck Kyrish4 buys
Mark Christopher Murray4 buys
Ganesh Moorthy3 buys
Scott McDougald Sutton2 buys
Ashley B. Duffie1 buy
Deborah J. Kissire1 buy
+3 other insiders
Since the insiders bought
- +4.0%Entry US$44.65 · Close 15 Oct 2026 US$46.44
- +1.7%Entry US$45.66 · Close 15 Oct 2026 US$46.44
- +4.8%Entry US$44.30 · Close 15 Oct 2026 US$46.44
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Celanese Corp Buy (bullish), based on 18 analysts. Average price target: US$61.06.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 18,488 of 24,148 companies
33.3
score / 100
Value49
Quality17
FCF yld16%
Earn yld-23%
EV/EBITDA·
ROE-22%
Gross mgn20%
Net mgn-12%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$46.44
Analyst consensus
18 analystsBuy
US$46.00Target US$61.06(+31%)US$86.00
Income statement
RevenueUS$9.5B
Gross profitUS$2B20% margin
EBITDAUS$267M3% margin
Net income-US$1.2B-12.0% margin
Valuation
PER (forward)7.7x
P/Book1.2x
Beta0.76
Balance sheet & cash
Market capUS$5.1B
Total debtUS$12.9B
Free Cash FlowUS$803M
Debt / Equity270%
Profitability & ownership
ROE-22.3%
ROA2.6%
% insiders0.4%
% institutions112.0%
Last declaration on 17 August 2026
Declarations186 total
1,400 shares@ US$45.52990.0012% mcap20.7% of flowCommon StockSEC:0002000660-26-000004:0
Canonical exit: 12 Nov 2026 (T+90)
100 shares@ US$45.5050.0001% mcap1.5% of flowCommon StockSEC:0002000660-26-000004:1
Canonical exit: 12 Nov 2026 (T+90)
800 shares@ US$45.50720.0007% mcap11.8% of flowCommon StockSEC:0002000660-26-000004:2
Canonical exit: 12 Nov 2026 (T+90)
600 shares@ US$45.600.0005% mcap100.0% of flowCommon StockSEC:0002000487-26-000003:0
Canonical exit: 9 Nov 2026 (T+90)
1,930 shares0Common StockSEC:0001199009-26-000006:0
2,153 shares@ US$45.51990.0019% mcap10.3% of flowCommon StockSEC:0001800013-26-000003:0
Canonical exit: 9 Nov 2026 (T+90)
2,975 shares0Common StockSEC:0001218184-26-000003:0
50,623 shares0Common StockSEC:0001306830-26-000044:0
10,431 shares0Common StockSEC:0001306830-26-000039:0
10,431 shares0Common StockSEC:0001306830-26-000043:0
1,687 shares0Common StockSEC:0001306830-26-000042:0
15,678 shares0Common StockSEC:0001306830-26-000041:0
12,579 shares0Common StockSEC:0001306830-26-000040:0
3,336 shares0Common StockSEC:0001306830-26-000027:0
1,205 shares0Common StockSEC:0001306830-26-000026:0
401 shares0Common StockSEC:0001306830-26-000024:0
618 shares0Common StockSEC:0001306830-26-000023:0
173 shares0Common StockSEC:0001306830-26-000025:0
1,808.351 shares0Common StockSEC:0001306830-26-000005:0
3,800 shares@ US$41.58997.3% of flowCommon StockSEC:0001306830-25-000245:0
Canonical exit: 10 Mar 2026 (T+90)
5,000 shares@ US$41.0366.0% of flowCommon StockSEC:0001306830-25-000243:0
Canonical exit: 9 Mar 2026 (T+90)
2,980 shares0Common StockSEC:0001306830-25-000241:0
6,624 shares0Common StockSEC:0001306830-25-000240:0
500 shares@ US$46.3310.9% of flowCommon StockSEC:0001306830-25-000200:0
Canonical exit: 7 Dec 2025 (T+90)
2,017 shares@ US$41.838.8% of flowCommon StockSEC:0001306830-25-000198:0
Canonical exit: 12 Nov 2025 (T+90)
25 of 186 declarations
About Celanese Corp
Celanese Corp. (ticker: CE) is a U.S.-based company listed on the NYSE in the United States. It is a global specialty chemicals and advanced materials group with a clear industrial profile: the company formulates, manufactures, and commercializes differentiated chemistry solutions used across a broad set of end markets. For French-, Belgian-, and Swiss-based investors, Celanese is best viewed as a cyclical yet value-added materials business, with earnings driven by industrial demand, input-cost dynamics, and the company’s ability to hold pricing and manage spreads.
Celanese traces its roots back to 1918, when the original business was founded in the early era of cellulose chemistry. The modern Celanese corporation was reorganized in 2004, and today its global headquarters are in Irving, Texas, in the Dallas area. The company also highlights an international operating footprint, with manufacturing, commercial, and technical capabilities across North America, Europe, and Asia-Pacific. This geographic reach matters because Celanese sells into diversified industrial supply chains and serves customers that require local support, application development, and reliable global supply.
Read moreShow less
The business is organized around two core pillars: Engineered Materials and the Acetyl Chain. Engineered Materials covers high-performance polymer solutions for demanding applications such as automotive, electronics, medical devices, industrial components, and consumer products. Key product families include acetal copolymers (POM), polybutylene terephthalate (PBT), liquid crystal polymers (LCP), thermoplastic vulcanizates (TPV), nylons, and other specialty thermoplastics. These materials are typically selected when customers need lightweighting, precision, heat resistance, chemical resistance, or durable mechanical performance.
The Acetyl Chain is Celanese’s integrated acetyls platform, centered on intermediates such as acetic acid, acetic anhydride, and vinyl acetate monomer (VAM). These products feed a wide range of downstream uses in adhesives, coatings, industrial chemicals, consumer applications, and additional specialty value chains. This segment gives Celanese scale, integration, and operational leverage, while also exposing the company to commodity-like pricing swings and supply-demand cycles.
In competitive terms, Celanese occupies an attractive niche between commodity chemicals and pure specialty materials. The company’s advantage lies in its technical know-how, application engineering, customer intimacy, and the breadth of its portfolio. That combination supports recurring relationships with industrial customers and helps Celanese defend margins through the cycle, although performance remains sensitive to raw-material costs, plant utilization, and end-market conditions.
Recent items investors should note include ongoing SEC Form 4 insider activity. The latest insider filings show multiple equity awards to executives and directors, alongside selected insider purchases by senior leaders in late 2025 and early 2026. From an analytical standpoint, those filings are worth monitoring because they can offer signals about management’s confidence and long-term alignment. Celanese has also continued to emphasize portfolio optimization, operational discipline, and sustainable-product initiatives across both business segments.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
